Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Kb-0742
2. 2416873-83-9
3. Chembl5199065
4. Kb0742
5. Istisociclib (usan)
6. Istisociclib [usan]
7. (1s,3s)-3-n-(5-pentan-3-ylpyrazolo[1,5-a]pyrimidin-7-yl)cyclopentane-1,3-diamine
8. (1s,3s)-n1-(5-(pentan-3-yl)pyrazolo[1,5-a]pyrimidin-7-yl)cyclopentane-1,3-diamine
9. Istisociclib [inn]
10. F7j6ksy5i8
11. Kb0742 2hcl
12. Orb1089900
13. Kb-0742 Hcl?
14. Schembl21877722
15. Gtpl13068
16. Ex-a6433
17. Bdbm50593922
18. Nsc834161
19. Nsc-834161
20. Compound 28 [pmid: 37967851]
21. Ub-18422
22. Hy-137478
23. Kb-130742
24. Cs-0139025
25. Kb-00130742
26. D12868
27. (1s,3s)-3-amino-1-[5-(1-ethylpropyl)-1,4,7a-triazainden-7-ylamino]cyclopentane
28. (1s,3s)-n1-[5-(1-ethylpropyl)pyrazolo[1,5-a]pyrimidin-7-yl]-1,3-cyclopentanediamine
29. 1,3-cyclopentanediamine, N1-[5-(1-ethylpropyl)pyrazolo[1,5-a]pyrimidin-7-yl]-, (1s,3s)-
| Molecular Weight | 287.40 g/mol |
|---|---|
| Molecular Formula | C16H25N5 |
| XLogP3 | 2.6 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 5 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 68.2 |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 333 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
92
PharmaCompass offers a list of Istisociclib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Istisociclib manufacturer or Istisociclib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Istisociclib manufacturer or Istisociclib supplier.
A Istisociclib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Istisociclib, including repackagers and relabelers. The FDA regulates Istisociclib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Istisociclib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Istisociclib supplier is an individual or a company that provides Istisociclib active pharmaceutical ingredient (API) or Istisociclib finished formulations upon request. The Istisociclib suppliers may include Istisociclib API manufacturers, exporters, distributors and traders.
click here to find a list of Istisociclib suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Istisociclib as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Istisociclib API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Istisociclib as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Istisociclib and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Istisociclib NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Istisociclib suppliers with NDC on PharmaCompass.
Istisociclib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Istisociclib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Istisociclib GMP manufacturer or Istisociclib GMP API supplier for your needs.
A Istisociclib CoA (Certificate of Analysis) is a formal document that attests to Istisociclib's compliance with Istisociclib specifications and serves as a tool for batch-level quality control.
Istisociclib CoA mostly includes findings from lab analyses of a specific batch. For each Istisociclib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Istisociclib may be tested according to a variety of international standards, such as European Pharmacopoeia (Istisociclib EP), Istisociclib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Istisociclib USP).